Education
About Us
Working with TipRanks
Follow Us
NuGene International Inc (NUGN)
OTHER OTC:NUGN
Total Valuation
NuGene International has a market cap or net worth of $1.41M. The enterprise value is ―.
Market Cap$1.41M
Enterprise Value―
Share Statistics
NuGene International has 830,440,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding830,440,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NuGene International’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.07%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-14.07%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee182.34K
Profits Per Employee-595.10K
Employee Count11
Asset Turnover0.04
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NuGene International is -1.48. NuGene International’s PEG ratio is >-0.01.
PE Ratio-1.48
PS Ratio0.00
PB Ratio0.22
Price to Fair Value0.22
Price to FCF-5.26
Price to Operating Cash Flow-22.33
PEG Ratio>-0.01
Income Statement
In the last 12 months, NuGene International had revenue of 2.01M and earned -6.55M in profits. Earnings per share was -0.01.
Revenue2.01M
Gross Profit-934.77K
Operating Income-6.55M
Pretax Income-6.55M
Net Income-6.55M
EBITDA-4.70M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -85.03K and capital expenditures -206.96K, giving a free cash flow of -291.99K billion.
Operating Cash Flow-85.03K
Free Cash Flow-291.99K
Free Cash Flow per Share>-0.01
Dividends & Yields
NuGene International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.41
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)233.12K
Important Dates
NuGene International upcoming earnings date is Aug 14, 2023, TBA Not Confirmed.
Last Earnings DateOct 27, 2022
Next Earnings DateAug 14, 2023
Ex-Dividend Date―
Financial Position
NuGene International as a current ratio of 2.61, with Debt / Equity ratio of 0.06%
Current Ratio2.61
Quick Ratio2.61
Debt to Market Cap<0.01
Net Debt to EBITDA-0.01
Interest Coverage Ratio-626.87
Taxes
In the past 12 months, NuGene International has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NuGene International EV to EBITDA ratio is -2.07, with an EV/FCF ratio of -5.29.
EV to Sales4.85
EV to EBITDA-2.07
EV to Free Cash Flow-5.29
EV to Operating Cash Flow-22.46
Balance Sheet
NuGene International has $2.64K in cash and marketable securities with $26.38K in debt, giving a net cash position of $23.74K billion.
Cash & Marketable Securities$2.64K
Total Debt$26.38K
Net Cash$23.74K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is -52.36%, with operating margin of -326.38%, and net profit margin of -326.36%.
Gross Margin-52.36%
Operating Margin-326.38%
Pretax Margin-326.36%
Net Profit Margin-326.36%
EBITDA Margin-234.13%
EBIT Margin-325.84%
Analyst Forecast
The average price target for NuGene International is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―